Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation by unknown
Available online http://arthritis-research.com/content/9/6/R120Open AccessVol 9 No 6Research article
Recruitment of dendritic cells and macrophages during T 
cell-mediated synovial inflammation
Mahin Moghaddami1, Leslie G Cleland1,2, Gorjana Radisic3 and Graham Mayrhofer1,3
1Arthritis Research Laboratory, Hanson Research Institute, Institute of Medical and Veterinary Science, Frome Road, Adelaide, South Australia, 5000, 
Australia
2Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, 5000, Australia
3Discipline of Microbiology and Immunology, School of Molecular and Biomedical Science, University of Adelaide, North Terrace, Adelaide, South 
Australia, 5005, Australia
Corresponding author: Graham Mayrhofer, graham.mayrhofer@adelaide.edu.au
Received: 19 Apr 2007 Revisions requested: 22 Jun 2007 Revisions received: 8 Oct 2007 Accepted: 20 Nov 2007 Published: 20 Nov 2007
Arthritis Research & Therapy 2007, 9:R120 (doi:10.1186/ar2328)
This article is online at: http://arthritis-research.com/content/9/6/R120
© 2007 Moghaddami et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Adoptive transfer of adjuvant-induced arthritis was used in this
study to examine local macrophages and dendritic cells (DCs)
during T cell-mediated synovial inflammation. We studied the
influx of CD11b+CD11c+ putative myeloid DCs and other non-
lymphoid CD45+ cells into synovium-rich tissues (SRTs) of the
affected hind paws in response to a pulse of autoreactive
thoracic duct cells. Cells were prepared from the SRTs using a
collagenase perfusion-digestion technique, thus allowing
enumeration and phenotypic analysis by flow cytometry.
Numbers of CD45+ cells increased during the first 6 days, with
increases in CD45+MHC (major histocompatibility complex) II+
monocyte-like cells from as early as day 3 after transfer. In
contrast, typical MHC II- monocytes, mainly of the CD4- subset,
did not increase until 12 to 14 days after cell transfer, coinciding
with the main influx of polymorphonuclear cells. By day 14,
CD45+MHC IIhi cells constituted approximately half of all CD45+
cells in SRT. Most of the MHC IIhi cells expressed CD11c and
CD11b and represented putative myeloid DCs, whereas only
approximately 20% were CD163+ macrophages. Less than 5%
of the MHC IIhi cells in inflamed SRT were CD11b-, setting a
maximum for any influx of plasmacytoid DCs. Of the putative
myeloid DCs, a third expressed CD4 and both the CD4+ and the
CD4- subsets expressed the co-stimulatory molecule CD172a.
Early accumulation of MHC IIhiCD11c+ monocyte-like cells
during the early phase of T cell-mediated inflammation, relative
to typical MHC II- blood monocytes, suggests that recruited
monocytes differentiate rapidly toward the DC lineage at this
stage in the disease process. However, it is possible also that
the MHC IIhiCD11c+ cells originate from a specific subset of
DC-like circulating mononuclear cells.
Introduction
Dendritic cells (DCs) differentiate from different progenitors,
with lymphoid or plasmacytoid DCs (pDCs) arising from a
common lymphoid progenitor and myeloid DCs (mDCs) shar-
ing a common lineage with monocytes and macrophages (Mϕ)
[1,2]. Myeloid DCs can arise from lineage-committed circulat-
ing precursors [3,4], from monocytes [5], or from a specific
subset of monocytes [6]. The function of mDCs in initiating
immune responses and their potential role in maintenance of
peripheral tolerance of T cells have been comparatively well
studied [7,8]. However, less is known about interactions
between effector T cells and DCs at sites of T cell-mediated
inflammation. The DC life cycle often is described in terms of
acute infection, where immature cells differentiate in response
to pathogen-associated recognition patterns and migrate to
the regional lymph nodes carrying microbial antigens [7,9].
However, at sites of chronic T cell-mediated inflammation,
maturation of DCs appears to involve antigen-specific effector
T cells and the cells remain locally [10,11], thus focusing the
inflammatory response.Page 1 of 13
(page number not for citation purposes)
AA = adjuvant-induced arthritis; APC = antigen-presenting cell; CFA = complete Freund's adjuvant; DA = Dark Agouti; DC = dendritic cell; FITC = 
fluorescein isothiocyanate; Ig = immunoglobulin; Mϕ = macrophage(s); mAb = monoclonal antibody; mDC = myeloid dendritic cell; MHC = major 
histocompatibility complex; NMS = normal mouse serum; pDC = plasmacytoid dendritic cell; PE = phycoerythrin; PMN = polymorphonuclear; SRT 
= synovium-rich tissue; TD = thoracic duct; TLR9 = Toll-like receptor 9.
Arthritis Research & Therapy    Vol 9 No 6    Moghaddami et al.In an autoimmune disease such as rheumatoid arthritis, the
presence of large numbers of activated DCs in the affected
synovium [12,13] suggests that these cells present local
autoantigens to cognate effector T cells in situ [14,15]. How-
ever, studies on pathological specimens present a static pic-
ture, usually of established disease, and there is little
information available about the kinetics of recruitment of DC
precursors in the early rheumatoid lesion. Adjuvant-induced
arthritis (AA) provides a robust system in which to study the
effector phase of T cell-mediated inflammation [16-18]. Nine
days after inoculation of Dark Agouti (DA) strain rats with com-
plete Freund's adjuvant (CFA), the thoracic duct (TD) lymph
contains CD4+ T effector cells that transfer AA to syngeneic
recipients adoptively, without co-transfer of antigen-present-
ing cells (APCs) [18]. The donor T cells accumulate selectively
in synovial tissues and their arthritogenicity and local prolifera-
tion suggest that they respond to cognate antigen(s) pre-
sented by APCs in the affected synovium [19].
Recently, we studied potential APCs in synovium-rich tissues
(SRTs) prepared from healthy rats using a collagenase per-
fusion technique [20,21]. We identified a subset of endocytic
'indeterminate cells' that resemble mDCs. These cells
expressed high levels of surface major histocompatibility com-
plex (MHC) class II molecules but neither CD11c (DC lineage
marker) nor CD163 (Mϕ marker). The fate of these cells is
unknown, but in vitro they have the potential to differentiate
into typical DCs in the presence of granulocyte-macrophage
colony-stimulating factor [20]. In the present study, we used
adoptive transfer of AA to investigate the effects of a pulse of
pathogenic T cells on recruitment of mDC-like cells to inflamed
synovial tissues. Data are presented also on recruitment of
other blood-derived non-lymphoid cells, including monocytes,
Mϕ, polymorphonuclear (PMN) leukocytes, and a population
of CD11b- mononuclear cells. T cell-induced inflammation is
accompanied by increases in all of these cell types but espe-
cially in cells with the phenotypic characteristics of early DCs.
Materials and methods
Animals
Female inbred specific pathogen-free DA strain rats (6 weeks
old) were obtained from the Gilles Plains Animal Resource
Centre (Adelaide, Australia). Experimental protocols were
approved by the ethics committees of the Institute of Medical
and Veterinary Science and the University of Adelaide.
Immunological reagents
Monoclonal antibodies (mAbs) are listed in Table 1[20,22,23].
Table 1
Monoclonal antibodies
Molecule Monoclonal antibody Reference/Source
CD11a WT1 – Hybridoma supernatant [20]
CD11b WT5 – FITC BD Pharmingen (San Diego, CA, USA)
CD11c 8A2 – Purified AbD Serotec (Oxford, UK)
CD4 OX35 – Cy-chrome BD Pharmingen
CD5 OX19 – Hybridoma supernatant [22]
CD32 D34-485 – Purified BD Pharmingen
CD36 UA009 [23]
CD45RC OX22 – Hybridoma supernatant [22]
CD45R (B220) His 24 – Purified BD Pharmingen
CD54 IA29 – Hybridoma supernatant [20]
CD80 3H5 – Hybridoma supernatant [20]
CD86 24F – Purified [20]
CD90 OX7 – Hybridoma supernatant [22]
CD163 ED2 – Purified AbD Serotec
CD172a OX41 – Hybridoma supernatant [20]
MHC II OX6 – Phycoerythrin BD Pharmingen
IgG1 IB5 – Hybridoma supernatant [20]
IgG2a ID4.5 – Hybridoma supernatant [20]
CD, cluster of differentiation; FITC, fluorescein isothiocyanate; Ig, immunoglobulin; MHC, major histocompatibility complex.Page 2 of 13
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ocyanate (FITC)-conjugated goat anti-mouse immunoglobulin
(Ig), biotin-conjugated goat anti-mouse Ig, FITC-streptavidin,
and phycoerythrin (PE)-Cy-7-streptavidin were obtained from
BD Pharmingen (San Diego, CA, USA).
Induction of adjuvant-induced arthritis
Rats (7 weeks old) received 0.1 mL of CFA subcutaneously at
the base of the tail [18]. Essentially all DA rats developed pol-
yarthritis after this treatment.
Assessment of arthritis
Arthritis in each paw was assessed as follows: 0, no evidence
of arthritis; 1, a single focus of inflammation; 2, more than one
focus of inflammation; 3, confluent but not global swelling; and
4, severe global swelling of the entire paw. Therefore, the dis-
ease score for individual rats ranges between 0 and 16.
Adoptive transfer of arthritis
Arthritis was transferred adoptively to naive 7-week-old syn-
geneic rats by intravenous injection of 2 × 108 TD cells
obtained from donors 9 days after inoculation of CFA [18].
Such donors are referred to throughout as 'arthritic donors'. To
assess severity of arthritis and to prepare cells from hind-paw
SRT, groups of five rats were examined at days 3, 6, 9, 12, and
14 after adoptive transfer. Five healthy rats were included as
controls.
Isolation of cells from synovium-rich tissue
Single-cell suspensions were obtained from the SRT of the
hind paws by a collagenase perfusion technique, as described
previously [20]. The viability of the leukocytes obtained from
SRT was routinely greater than 95% by exclusion of Trypan
blue.
Immunofluorescence staining of cells
Staining for dual-color immunofluorescence was performed on
aliquots of 1 to 2 × 105 cells by means of a combination of indi-
rect and direct techniques [20].
For four-color analysis, cells were first labelled indirectly using
purified mAb, followed by biotin-conjugated goat anti-mouse
Ig secondary antibody and streptavidin PE-Cy-7. After the
blocking of free valences by incubation with 20 μL of normal
mouse serum (NMS) for 20 minutes, the cells were incubated
with a cocktail of conjugated mAbs containing PE-OX6, FITC-
WT5, and Cy-chrome-OX35 and were washed and fixed with
1% paraformaldehyde.
Flow cytometry
Labelled cells were analysed with a Beckman Coulter EPICS
XL-MCL flow cytometer and Coulter EXPO 32 software
(Beckman Coulter, Fullerton, CA, USA). An electronic 'DC
gate' was based on the light-scatter properties of DCs from rat
pseudo-afferent lymph [20]. Populations of cells expressing
each cell surface marker were examined by analysis of at least
50,000 cells within this gate. Absolute cell numbers were esti-
mated by including known numbers of FITC-conjugated BD
CaliBRITE beads (BD Biosciences, San Jose, CA, USA) in
each sample [19].
Cell sorting
Cells from SRT were stained to detect either CD45 (FITC-
OX1, direct) and MHC class II (PE-OX6, direct), or CD11b
(FITC-WT5, direct), MHC class II (PE-OX6, direct), and CD4
(PE-CY5-OX35, direct). They were sorted using FACSDiva
software (BD Biosciences, San Jose, CA, USA) [20].
Immunocytochemistry and immunohistochemistry
Cytospin smears prepared from sorted cells were fixed and
stained essentially as described [20]. The primary antibodies
used for sorting were saturated with anti-mouse IgG1. The
smears then were incubated with undiluted NMS to block free
valences and were incubated further with anti-CD11c or anti-
CD163 antibodies or with isotype-matched irrelevant antibod-
ies. Bound anti-CD11c (IgG2a) or anti-CD163 (IgG1) then
was detected with biotinylated goat anti-mouse IgG2a or
IgG1, respectively, followed by streptavidin-peroxidase.
Bound peroxidase was detected as described previously [20].
For immunohistochemistry, inflamed tissue containing syn-
ovium was pared from the lateral side of the ankle and embed-
ded in OCT [19]. Frozen sections (5 μm) were fixed and
stained by the indirect immunoperoxidase technique as
described elsewhere [20].
Statistical analysis
Differences between mean cell numbers in experimental
groups were analysed where appropriate using one-way anal-
ysis of variance, with post-analysis by the Tukey-Kramer multi-
ple comparisons test. A p value of less than 0.05 between
groups was considered significant.
Results
Cell recovery from synovium-rich tissue during 
adoptively transferred arthritis
Recipients received 2 × 108 TD cells from arthritic donors by
intravenous injection. Consistent with previous findings [18],
mild transient inflammation was observed at day 3 after adop-
tive transfer and sustained paw swelling commenced from day
6, reaching a maximum at day 12 (Figure 1). Total viable cells
recovered from each pair of hind paws by collagenase diges-
tion had increased by day 3 after adoptive transfer and
reached approximately 1.5 × 107 between days 9 and 14.
Thus, cell yields and arthritis severity followed similar time
courses.
Dual-fluorochrome analysis of CD45+ cells prepared 
from synovium-rich tissue
The forward and side scatter of light by cells in an SRT prepa-
ration is shown in Figure 2a. Gate 'a' (the 'DC gate') is basedPage 3 of 13
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ods). In addition to containing DCs, this gate contains mono-
cytes, PMN cells, fibroblasts, and endothelial cells but
excludes essentially all lymphocytes (M. Moghaddami, L.G.
Cleland, G. Radisic, G. Mayrhofer, unpublished data). All anal-
yses described below were confined to cells in the 'DC gate',
whereas gate 'b' contained the fluorescent beads used for
measurement of cell numbers (see below).
Cells from SRT (n = 5 for each time point) were analysed first
by dual-fluorochrome flow cytometry (Figure 2b–i). When cells
from healthy rats were labelled with mAbs against CD45
(OX1, indirect FITC) and MHC class II (OX6, PE conjugate),
the CD45+ cells within the DC gate were found to consist of
MHC IIhi, MHC IIlo, and MHC II- subpopulations (Figure 2b).
The MHC IIhi and MHC IIlo/int subsets comprised approximately
30% and 12%, respectively, of the total CD45+ cells in SRT
from normal rats (Figure 2b). We have shown previously that
the MHC IIhi cells in healthy SRT consist mainly of CD11c-
CD163- 'indeterminate cells' and CD163+-activated Mϕ,
whereas MHC IIlo/int cells consist mainly of CD163+ Mϕ [20].
SRT preparations from healthy rats contained very few PMN
cells.
A distinct subset of CD45lo MHC II- cells was present at 14
days after adoptive transfer (Figure 2f). This population is seen
clearly when CD45+ events in Figure 2f are plotted as a histo-
gram (Figure 2j). Cytospin preparations of sorted CD45loMHC
II- cells showed that greater than 80% were PMN cells (not
shown). In contrast, the CD45hi cells incorporated the MHC IIhi
and MHC IIlo/int subsets and, when sorted, consisted entirely of
mononuclear cells (not shown). CD45hiMHC IIhi cells com-
prised 52% of the CD45+ cells at this time, compared with
30% in healthy rats. The sorted CD45hiMHC IIhi cells were het-
erogeneous in morphology (Figure 2k). Approximately 70%
resembled DCs at various stages of differentiation and approx-
imately 2% had veiled morphology (Figure 2k, upper inset). Of
the remaining cells, approximately 20% resembled monocytes
and 8% had the morphology of Mϕ (Figure 2k, lower inset).
When stained by the indirect immunoperoxidase technique,
the cells with Mϕ morphology were found to express CD163
(Figure 2m) but not CD11c (Figure 2l and inset). Conversely,
the cells with monocyte-like and DC morphology were found
to express CD11c (Figure 2l and inset) but not CD163 (Figure
2m). These immunohistochemical findings support the identi-
fication of Mϕ and DCs [20] and suggest that the monocyte-
like cells are related to DCs.
Further investigation and enumeration of CD45+ subsets 
in synovium-rich tissue after adoptive transfer of 
arthritogenic thoracic duct cells
Importantly, only CD45+ cells were found to express high lev-
els of MHC class II molecules. Thus, by gating MHC IIhi cells,
it was possible to study the expression of other molecules by
this subset, using only two fluorochromes. When aliquots of
cells were dual-labelled to detect MHC class II molecules plus
either CD11c or CD163, 90% of the MHC IIhi cells were found
to express CD11c (Figure 2g), 15% expressed CD163 (Fig-
ure 2h), and very few cells expressed neither marker. This con-
trasted with SRT from normal rats (Figure 2c,d), in which the
proportions of MHC IIhi cells that expressed either CD11c or
CD163 were 27% and 30%, respectively, whereas 43% were
negative for both markers. Therefore, compared with healthy
SRT, there are very few 'indeterminate' cells (expressing nei-
ther CD11c nor CD163) in the inflamed SRT.
The maturity of the MHC IIhi cells in SRT prepared from normal
rats and from rats with adoptively transferred AA was
assessed by examining expression of CD36 [24], using mAb
UA009 [23]. As shown in Figures 2e and 2i, the molecule was
expressed by most of the MHC IIhi cells. Thus, relative to DCs
in pseudo-afferent lymph, where most of the cells are not
stained by mAb UA009 (M. Moghaddami, L.G. Cleland, G.
Radisic, G. Mayrhofer, unpublished data), the majority of the
MHC IIhi cells in SRT have an immature phenotype. However,
the proportion of CD36+ cells was slightly higher in SRT from
healthy rats (87%) than in SRT from animals 14 days after
adoptive transfer (78%). This finding suggests that the propor-
tion of mature DCs is greater in SRT from inflamed paws.
Incorporation of CaliBRITE beads (Figure 2a) in the analysis
[19] allowed the numbers of cells in each subset to be calcu-
lated per pair of hind paws (Figure 3a,b,d). The mean total of
CD45+ cells in healthy SRT was 1 ± 0.18 × 106 per pair of
hind paws (Figure 3a). In SRT preparations from rats 3, 6, 9,
12, and 14 days after adoptive transfer, the numbers
Figure 1
Viable cells recovered from hind paws of rats with adoptively trans-ferred adjuvant-induced arthritis and joint scores
ferred adjuvant-induced arthritis and joint scores. Rats received 2 × 
108 thoracic duct cells obtained from syngeneic donors 9 days after 
inoculation with complete Freund's adjuvant. At the times indicated, 
arthritis was scored in all paws and cells then were prepared from the 
synovium-rich tissues of the hind paws by intra-arterial perfusion with 
collagenase (Materials and methods). Black indicates total viable cells 
per pair of hind paws (mean ± standard deviation [SD], n = 5). Gray 
indicates joint score (mean ± SD, n = 5).Page 4 of 13
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to reach 6.4 ± 2.8 × 106 at day 14 after transfer.
MHC IIhi cells outnumbered MHC IIlo/int cells at all times. The
MHC IIhi cells had increased approximately 10-fold by day 14
after adoptive transfer (p < 0.01 compared with healthy, p <
0.05 compared with day 3 or day 6), and MHC IIlo/int cells were
also more numerous than either in healthy rats (p < 0.01) or at
days 3 to 6 after transfer (p < 0.05) (Figure 3a). Within these
subsets, presumptive Mϕ were identified by expression of
CD163 (Figure 3b). The numbers of MHC IIhiCD163+ cells
increased progressively over the 14 days after adoptive trans-
fer. Numbers of MHC IIlo/-CD163+ cells also increased until
day 12 but then decreased to levels similar to normal SRT by
day 14. Thus, except at day 14, MHC IIlo/- Mϕ predominated in
both normal and inflamed SRT.
MHC II- cells also increased from approximately day 6 after
adoptive transfer and, by day 14, were as numerous as the
MHC IIhi cells (Figure 3a). As discussed above, most of the
MHC II- cells were PMN cells. However, this population also
contains presumptive monocytes and the kinetics of recruit-
Figure 2
Dual-color flow cytometry and cytospin preparations of sorted CD45+MHC IIhi cells from synovium-rich tissue (SRT) of hind paws. (a) Forward scat-
ter (FS) and side scatter (SS) of light, showing a gate ('dendritic cell [DC] gate') based on the light scatter of DCs in rat pseudo-afferent lymph (a) 
and a gate containing the CaliBRITE beads used to calculate absolute numbers of cells (b). Cells expressing MHC class II molecules in SRT from a 
healthy rat (b-e) and from a rat 14 days after adoptive transfer of arthritis (f-i). All MHC II+ cells express CD45 (b, f). However, when CD45 events in 
(f) are plotted as a histogram (j), the MHC II- events (predominantly polymorphonuclear cells) express lower levels of CD45 than the MHC IIhi events 
(mononuclear cells). After adoptive transfer, more MHC IIhi cells express CD11c (c, g) and CD36 (e, i) but a minority express CD163 (d, h). Per-
centages indicate proportions of CD45+ cells that express indicated levels of MHC class II molecules (b, f) or MHC IIhi cells that express CD11c (c, 
g), CD163 (d, h), or CD36 (e, i). Morphology of CD45+MHC IIhi cells from SRT obtained 12 days after adoptive transfer of arthritis. The cells were 
sorted by fluorescence-activated cell sorting, and smears were prepared by cytospin (k-m). Giemsa stain shows that most cells have DC morphol-
ogy (arrows), a few have veils (top inset), and a few (lower inset) have macrophage morphology (k). Indirect immunoperoxidase staining shows that 
cells with DC morphology (arrow and inset), but not macrophage morphology (arrowheads and inset), express CD11c (l). DCs did not express 
CD163 (arrows) but this antigen was expressed strongly by macrophages (arrowheads) (m). Objective, × 60. MHC, major histocompatibility 
complex.Page 5 of 13
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below.
In addition, dual-fluorochrome analysis of CD80, CD86, and
CD54 expression was performed on the MHC IIhi cells (not
shown). The proportions of MHC IIhi cells that express these
markers are shown in Figure 3c. The proportions of CD86+
cells remained relatively constant (70% to 80%) after adoptive
transfer, whereas CD54+ cells increased slightly from 84% in
healthy SRT to 96% in SRT 14 days after transfer. In contrast,
there were significant increases in the proportions of CD11c+
and CD80+ cells over the same period. Importantly, the pro-
portion of CD163+ Mϕ remained unchanged, indicating that
the increased proportion of MHC II+CD80+ cells must be due
to an increase in DC-like cells. This conclusion is supported by
a parallel increase in the proportion of CD11c+ cells (Figure
3c). Estimates were also made of the numbers of MHC IIhi cells
expressing CD11c, CD54, CD80, CD86, and CD163 (Figure
3d). The subsets expressing each of these markers increased
during the period following adoptive transfer and for each, the
increase was roughly in proportion to the increase in total
MHC IIhi cells. Whereas there was an increase in Mϕ during
adoptively transferred arthritis (Figure 3d), there was no appre-
ciable change in the ratio of MHC IIhiCD163+ cells (Mϕ) to
MHC IIhiCD163- cells (presumptive DCs) in SRT (Figure 3c).
Four-fluorochrome analysis of CD11b+ and CD11b- 
subsets in synovium-rich tissue
A number of subsets of mDCs have been described in rats
[25-28]. A CD4+ subset is believed to be stimulatory, whereas
it is suggested that a CD4- subset has tolerizing functions
[25]. Furthermore, cells that resemble pDCs (MHC II+, CD4+,
CD11b-, and CD11c-) have been identified [29]. CD11b,
which is expressed by the myeloid lineage, distinguishes
mDCs from pDCs. Care is needed in making this distinction
because, under some circumstances, mDCs may express only
low tointermediate levels of CD11b [30,31].
Four-color analysis was applied to some of the SRT samples
described above (n = 2 for each time point) in order to extend
the phenotype of the MHC IIhi cells isolated from arthritic hind
paws. MHC IIhi cells (selected as in Figure 4a) could be
Figure 3
Cell numbers in synovium-rich tissue (SRT) of hind paws during the course of adoptively transferred arthritisi l  tr f  rt riti . Dual-color flow cytometry was used to 
analyse cell surface antigens, and CaliBRITE beads were used to estimate cell numbers per pair of hind paws (mean ± standard deviation, n = 5). 
(a) Numbers of total CD45+, CD45+MHC IIhi, CD45+MHC IIlo, and CD45+MHC II- cells in SRT prepared from normal rats and from rats 3 to 14 days 
after adoptive transfer of arthritis. (b) Numbers of MHC IIhi and MHC IIlo/- macrophages (CD45+CD163+ cells) in SRT after adoptive transfer of arthri-
tis. Cell surface antigen phenotype of CD45+MHC IIhi cells in SRT after adoptive transfer of arthritis, expressed as proportion of cells positive for 
each marker (c) and numbers of cells expressing the markers (d). MHC, major histocompatibility complex.Page 6 of 13
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CD11b-, CD4+CD11b+, and CD4-CD11b+ (Figure 4b). Anal-
ysis of the CD4+CD11b+ and CD4-CD11b+ subpopulations
showed that both consist mainly of CD11c+ cells (Figure 4c).
In the CD4+CD11b+ subset, the proportions of CD11c- and
CD163+ cells were approximately 43.5% and 33.5%, respec-
tively (Figure 4d), suggesting that most CD11c- cells are
CD163+MHC IIhi Mϕ. This was confirmed using cytospin prep-
arations of sorted CD4+CD11b+ cells, in which most had DC-
like or monocyte-like morphology (Figure 4e) but some were
typical Mϕ (inset). Approximately 10% of CD4+CD11b+ cells
appear to express neither CD11c nor CD163. Of the CD4-
CD11b+ cells, most had either DC-like (Figure 4f) or mono-
cyte-like (inset) morphology and most expressed CD11c
(75%) and only a few (11.5%) expressed CD163 (Figure
4c,d). As in the case of the CD4+CD11b+ subset, a small pro-
portion of MHC IIhiCD4-CD11b+ cells (approximately 14%)
did not express either CD11c or CD163 and both subsets
contain, therefore, a small number of 'indeterminate' cells.
The subpopulations of MHC IIhi cells in the CD11b- quadrants
(Figure 4b) do not appear to be of myeloid origin because they
do not express even low levels of CD11b. When sorted by flu-
orescence-activated cell sorting, the morphologies of the
CD4+CD11b- (approximately 1% of the MHC IIhi cells in the
DC gate) and CD4-CD11b- (approximately 4% of the MHC IIhi
cells in the DC gate) subsets were similar. Both consist of
small- to medium-sized mononuclear cells (Figure 4g,h)
resembling pDCs isolated from rat spleen [29]. However, only
approximately 5% to 10% express the B220 isoform of CD45
(not shown), which has been described on most rat spleen
pDCs [29]. Nevertheless, some of the cells in each subset
expressed CD45RC (20% and 40%, respectively), another
isoform of CD45 described by the same workers on rat spleen
pDCs. Furthermore, approximately half of the cells in these
subsets expressed CD86 and some expressed CD80 (20%
and 32%, respectively), consistent with at least some being
DCs. The CD4+CD11b- and CD4-CD11b- subsets have simi-
larities in expression of CD11c (75% and 65%), CD54 (70%
and 90%), CD172a (60% and 66%), CD11a (60% and 96%),
CD32 (50% and 95%), and/or CD5 (20% and 32%). The two
subsets also have similarities with putative MHC II+CD4-
CD11b-CD11c+ precursors of CD4+ pDCs in mice [32]. Fur-
ther work is required to determine the functional characteris-
tics of these cells, in particular their response to stimulation
with Toll-like receptor 9 (TLR9) agonists [29].
Changes in numbers of myeloid-derived and CD11b- cells 
during adoptively transferred arthritis
As a proportion of CD45+MHC IIhi cells, the
CD4+CD11b+CD163- and CD4-CD11b+CD163- subsets
remained relatively constant throughout adoptively transferred
Figure 4
Four-color flow cytometry and cytospin preparations of sorted subsets from synovium-rich tissue 14 days after adoptive transfer. The MHC IIhi cells 
(a) were analysed for expression of CD4 and/or CD11b (b). The fourth fluorochrome was used to detect expression of either CD11c (c) or CD163 
(d) by the CD11b+ subsets. (e) Giemsa-stained cytospin preparations of the sorted CD11b+CD4+ subpopulation consisted mainly of cells with den-
dritic cell (DC) (arrows) or monocyte-like (arrowhead) morphology with a few cells of typical macrophage morphology (inset). (f) Giemsa-stained cyt-
ospin preparations of the sorted CD11b+CD4- subpopulation consisted mainly of cells with DC (arrows) or monocyte-like (arrowhead and inset) 
morphology. The sorted CD11b-CD4+ (g) and CD11b-CD4- (h) cells had morphology consistent with that described for plasmacytoid DCs. Objec-
tive, × 60. MHC, major histocompatibility complex.Page 7 of 13
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subsets increased approximately 10-fold by day 14 after trans-
fer (Figure 5a). The numbers of MHC IIhiCD11b- cells were
also estimated (not shown). The CD4+CD11b- and CD4-
CD11b- subsets increased approximately 5- and 10-fold,
respectively, by day 14 after transfer but remained unchanged
as a proportion of MHC IIhi cells (1% and 5%, respectively).
As noted using dual-fluorochrome analysis (Figure 3b), num-
bers of CD163+ Mϕ increased during adoptively transferred
AA. Four-fluorochrome analysis resolved Mϕ into CD4+ and
CD4- subsets (Figure 5c,d). In both the MHC IIhi and MHC IIlo/-
subsets, there was a consistent trend toward increased num-
bers of CD4- Mϕ late in the disease (days 9 to 14), as shown
in Figure 5c. The significance of the sharp increase in CD4+
Mϕ at day 12, in both the MHC IIhi and MHC IIlo/- subsets, is
unclear and requires further investigation in additional animals.
To compare the influx of DCs and Mϕ with other inflammatory
cells, data from four-fluorochrome analysis were used to iden-
tify monocytes (MHC II-CD163lo) [20] and PMN cells
(deduced phenotype MHC II-CD11b+CD4-CD163-) amongst
the MHC II- cells in SRT. Numbers of PMN cells in normal SRT
were small and there were no significant changes during the
first 6 days after adoptive transfer (Figure 5e). By day 9, there
was a small increase in the numbers of PMN cells and this
accelerated rapidly over the following 5 days. These results
were consistent with the numbers of PMN cells (CD45+MHC
II-) observed by dual-flurochrome analysis (Figure 3a) and with
histological examination of synovial tissue at day 9 after adop-
tive transfer. Monocytes could be divided into MHC II-
CD11b+CD4+CD163lo and MHC II-CD11b+CD4-CD163lo
subsets. Only small numbers of CD4+ and CD4- monocytes
were observed in healthy SRT. The numbers of CD4+ mono-
cytes did not change significantly throughout adoptively trans-
ferred disease (Figure 5e). In contrast, CD4- monocytes
increased approximately 30-fold between days 9 and 12 com-
pared with healthy rats and remained at 15-fold that of healthy
levels at day 14.
Surface antigen phenotype of the CD4+CD11b+ and CD4-
CD11b+ subsets of putative myeloid dendritic cells
Individual markers expressed by the CD4+CD11b+ and CD4-
CD11b+ subsets during the course of adoptively transferred
disease are shown in Figure 6. The proportion of cells express-
ing CD11c increased markedly between days 9 to 14 of the
disease (Figure 6a,b). This increase was more pronounced in
the CD4-CD11b+ subset, in which between 75% and 90% of
CD4-CD11b+ cells expressed CD11c during this period (Fig-
ure 6b) compared with 55% to 60% of the CD4+CD11b+ sub-
set (Figure 6a). The proportions of cells expressing CD80 and
CD11a also increased during this time in both populations, but
the proportion expressing CD86 remained essentially
unchanged. At all times, essentially all cells in both
subpopulations expressed CD54 and CD32 (Figure 6a,b). In
contrast to DCs in afferent lymph [25], the majority of both
CD4- and CD4+ cells in SRT expressed CD172a (Figure 6).
Interestingly, most of the cells in both subsets expressed
CD90 (data not shown).
Location of putative dendritic cells and macrophages in 
synovium-rich tissue
The soft tissues of the skinned hind paws contain multiple diar-
throdial joints and tendon sheaths, with their associated syno-
vial linings and subintimal connective tissues (Figure 7a).
However, they also contain tendons, loose areolar connective
tissue, adipose tissue, and muscle, plus vascular and nerve tis-
sues. Nine days after adoptive transfer, the subintimal tissues
contained many mononuclear cells (Figure 7a) and
granulocytes (Figure 7b). Immunohistochemical examination
revealed a dense infiltration of the inflamed synovium and sur-
rounding connective tissues with CD45+ cells (Figure 7d),
consisting of both mononuclear and PMN leukocytes. Densely
stained MHC II+ mononuclear cells (Figure 7e) were present in
both the synovial lining and the subintimal tissues, and a large
number of lightly stained CD11c+ cells (Figure 7g) were scat-
tered in the subintima. The latter cells exhibited both monocyte
and DC morphology (Figure 7h and inset). In contrast,
CD163+ cells were fewer in number (Figure 7f) and most were
located in the synovial lining (type A synoviocytes), with only
scattered cells in the subintimal connective tissue. These
observations provide qualitative support to the quantitative
studies on inflammatory cells obtained from SRT by enzymatic
digestion (Figure 3c). Importantly, they show that Mϕ are a
numerically small subset of the total CD45+ cells in the
inflamed synovial tissues during adoptively transferred AA
whereas MHC II+ and CD11c+ cells are much more abundant.
Discussion
Adoptive transfer of AA in DA strain rats provides an excellent
model in which to study APCs during the effector phase of T
cell-mediated autoimmunity. Firstly, activated CD4+ T cells
from central lymph of arthritic donors transfer the disease with-
out ex vivo stimulation [18] and the cells are recruited selec-
tively to the SRT, where they proliferate [19]. Transfer of AA
does not require donor APCs [18], suggesting that APCs in
normal synovium are effective in presenting cognate autoanti-
gen(s). Secondly, the enzymatic digestion technique yields a
representative population of viable cells from SRT [20,21],
allowing examination of cell subsets during adoptively trans-
ferred disease and estimation of numbers of cells in the vari-
ous subsets by calibrated flow cytometry. Estimation of
numbers of acute inflammatory cells in SRT allows changes in
mononuclear cell subsets to be correlated with other
manifestations of inflammation. Importantly, immunohisto-
chemical studies indicate that disaggregated SRT cells are
representative of cells within the synovium.
The hind paws were mildly inflamed within 3 to 6 days of trans-
fer of arthritogenic cells, a time when donor T cells are alreadyPage 8 of 13
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Four-color flow cytometry of subsets from synovium-rich tissue (SRT) following adoptive transfer of arthritis. Cell numbers per pair of hind paws 
(mean, n = 2) were estimated by use of CaliBRITE beads. (a) Numbers of putative dendritic cells (MHC IIhiCD163- cells) with CD4+CD11b+ or 
CD4-CD11b+ phenotype. (b) Proportions of the same subpopulations. Numbers of CD4- and CD4+ macrophages in the MHC IIhi (c) and MHC IIlo/- 
(d) subpopulations of CD45+CD163+ cells. (e) Numbers of MHC II-CD45+ cells in SRT after adoptive transfer of arthritis. MHC II- cells with the phe-
notype CD11b+CD4-CD163- were defined as polymorphonuclear (PMN) cells, whereas those with the phenotypes CD11b+CD4-CD163lo and 
CD11b+CD4+CD163lo were designated as monocytes. MHC, major histocompatibility complex.Page 9 of 13
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SRT increased, reaching sustained levels by days 9 to 12 after
transfer. Whereas the numbers of CD45+ cells increased dur-
ing the first 6 days, PMN cells and typical inflammatory mono-
cytes did not increase until days 9 to 12 and days 12 to 14,
respectively. The delayed appearance of MHC II- cells (mainly
PMN cells), which comprised approximately 92% of
CD45+MHC II- cells in SRT by day 14 (Figure 5e), suggests
that their recruitment is related indirectly to T cells, possibly
involving factors produced by immature and mature DCs [33].
Monocytes, defined herein as circulating non-lymphoid mono-
nuclear cells with the phenotype MHC II-CD11c+CD163lo
[20], did not increase in number until late in the inflammatory
process. This apparent delay in recruitment of monocytes may
indicate that monocytes that migrate earlier in the disease
process express MHC II molecules soon after recruitment, giv-
ing rise to the MHC IIhi monocyte-like population. The
presence of MHC IIhi cells with monocyte-like morphology
(Figure 2k) which express CD11c (Figure 2l) and CD163 (Fig-
ure 2m) supports this notion. Similar MHC IIhi monocyte-like
cells in SRT from healthy rats are highly endocytic [21], sug-
gesting that this population is functionally similar to DCs. The
Figure 6
Phenotype of CD4+CD11b+ and CD4-CD11b+ subpopulations of MHC IIhi cells in synovium-rich tissue at indicated times after adoptive transfer of arthritogenic thoracic d ct cells
MHC IIhi cells in synovium-rich tissue at indicated times after adoptive 
transfer of arthritogenic thoracic duct cells. Cell surface phenotype was 
determined by four-color flow cytometry (Figure 4). The CD4+ (a) and 
CD4- (b) subpopulations of MHC IIhi CD11b+ cells identified in Figure 4 
were assessed by use of a fourth fluorochrome. Proportions of the 
MHC IIhi cells expressing respective surface markers are shown. 
Means, n = 2. MHC, major histocompatibility complex.
Figure 7
Location and phenotype of putative dendritic cells (DCs) and macro-phages in inflam d tissue
phages in inflamed tissue. Frozen sections prepared from a block of 
inflamed tissue containing synovium are shown. Tissue was obtained 
from the lateral side of the ankle 9 days after adoptive transfer of arthri-
tis. (a) Frozen section showing inflamed synovial lining (arrow), subinti-
mal connective tissue (CT), and tendon (T), stained with hematoxylin 
and eosin. (b) High-power view of area from box in (a) shows polymor-
phonuclear cells. (c) Indirect immunoperoxidase, isotype-matched con-
trol monoclonal antibody (mAb). (d) Section stained with mAb OX1 
showing dense infiltration of the synovial lining and subintimal connec-
tive tissue with CD45+ cells. (e) Staining with mAb OX6 shows large 
number of MHC II+ cells in the synovial lining and subintimal connective 
tissue. (f) CD163+ cells stained by mAb ED2 are located mainly in the 
synovial lining as type A synoviocytes and are present in the subintimal 
connective tissue in small numbers. (g) CD11c+ cells, stained by mAb 
8A2, are located mainly in the subintimal connective tissue. (h) High-
power view of area from box in (g) shows CD11c+ monocytes (arrow-
heads) and DC-like cells (arrow and inset). Objectives, × 60. MHC, 
major histocompatibility complex.Page 10 of 13
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adoptively transferred arthritis, therefore, could reflect a
decline in factors responsible for upregulating expression of
MHC class II molecules. Most of the monocytes in inflamed
SRT belong to the CD4- subset, consistent with the descrip-
tion of CD43loCD4- 'inflammatory' monocytes in rats [34].
In healthy SRT, approximately 70% of the CD45+ cells had the
phenotype MHC IIlo/- and most of these were CD163+ Mϕ
(Figure 2b–d). Following adoptive transfer, total Mϕ increased
approximately two-fold. The proportion of total Mϕ that
expressed high levels of MHC class II molecules increased
progressively from 20% in normal SRT to 60% at day 14 after
adoptive transfer, with the greatest change being in the MHC
IIhi CD4- subset (Figure 5c). Numbers of MHC IIlo/- Mϕ also
increased, suggesting that recruitment of new MHC IIlo/- Mϕ
balances conversion into MHC IIhi cells (Figure 3b). Interest-
ingly, the proportions of MHC IIhiCD163- and MHC IIhiCD163+
cells remained similar throughout the period of observation
(Figure 3c), indicating that control of the commitment to differ-
entiation into DCs or Mϕ was unchanged by the presence of
autoreactive T cells.
Total MHC IIhi cells in SRT increased 10-fold following transfer
of arthritogenic TD cells (Figure 3a). While at least 40% of the
MHC IIhi cells in healthy SRT are 'indeterminate', expressing
neither CD11c nor CD163 [20], the numbers and proportions
of CD11c+ cells increased following adoptive transfer (Figure
3c). By day 14, only 10% of the MHC IIhi cells did not express
CD11c and only 15% expressed CD163 (Figure 2g,h). There-
fore, the proportion of 'indeterminate' cells must be less than
10% and the additional MHC IIhi cells appear committed to the
DC lineage. Increasing numbers of MHC IIhi cells expressed
the activation markers CD80, CD86, and CD54 (Figure 3d),
and the increase in proportion of cells expressing CD80
paralleled the expression of CD11c (Figure 3c). However, the
majority of these DC-like cells expressed CD36, indicating
that most are not mature DCs [24]. Unlike DCs in mesenteric
pseudo-afferent lymph, where most express CD103 (αE2
integrin chain) [35], the vast majority (99%) of MHC II+ cells in
SRT lacked this marker (data not shown). Rat DCs are heter-
ogeneous in expression of CD103 [36], and our results indi-
cate that the DC-like cells in SRT resemble veiled cells in rat
peripheral afferent lymph, where the majority do not express
the molecule (M. Moghaddami, L.G. Cleland, G. Radisic, G.
Mayrhofer, unpublished data).
The additional MHC IIhi putative DCs in SRT during adoptively
transferred disease could reflect increased recruitment of cir-
culating DC precursors [5,37] and/or greater retention of DCs
in the tissues [10,11]. Our observations herein, and studies
using genetically marked donor monocytes (B. Herdman, M.
Moghaddami, G. Mayrhofer, unpublished data), indicate that
CD4- monocytes are recruited to the SRT of the hind paws
during adoptively transferred AA. Monocytes are activated by
exposure to interferon-gamma and during the process of
extravasation [38,39]. The activated cells upregulate expres-
sion of MHC II molecules and may downregulate CD11c and
CD163 [40]. Our results suggest that differentiation of 'inde-
terminate' cells into DCs is accelerated in tissues undergoing
T cell-mediated inflammation. An origin of DCs from
monocyte-like cells is consistent with the morphological diver-
sity of the MHC IIhi cells from SRT.
The majority of MHC IIhi cells in SRT during adoptively trans-
ferred disease expressed the myeloid marker CD11b, and of
these, most expressed CD11c but not CD163. Only approxi-
mately one third of the CD11b+ cells in SRT expressed CD4,
showing that the dichotomy of CD4+ and CD4- veiled cells in
rat pseudo-afferent lymph [25] exists already in SRT. Whereas
numbers of CD4+ and CD4- cells increased after the initiation
of disease, the proportions remained relatively constant. Both
subpopulations exhibited a progressive increase in the propor-
tion of cells expressing CD80, CD86, and CD11a, and impor-
tantly, both expressed CD172a, a molecule expressed only by
the CD4+ subset of veiled cells [25]. Moreover, similar propor-
tions of the CD4+ and CD4- subsets in SRT expressed CD90
(data not shown), whereas it is reported that few CD4-
CD172a- DCs in rat spleen express CD90 compared with the
CD4+ CD172a+ subset [28]. The presence of CD4-
CD172a+CD90+ cells in SRT from both healthy and arthritic
rats indicates that this phenotype is not a response to inflam-
mation. Downregulation of CD172a, therefore, may be an
event that precedes migration of CD4- cells from the tissues.
Because CD172a has possible co-stimulatory importance
[41], its downregulation could signal a switch in the CD4- sub-
set from a stimulatory function to one of maintaining peripheral
tolerance [25].
Finally, we have identified MHC IIhiCD11b- cells in SRT. The
CD4- and CD4+ subsets represent only 5% and 1%, respec-
tively, of the total MHC IIhi cells in SRT, and although their num-
bers increased, the relative proportions were similar in healthy
and arthritic rats. These cells do not appear to be CD11lo TNF/
iNOS-producing DCs of the sort described by Serbina and
colleagues [30]. They express high levels of MHC class II mol-
ecules, many express the co-stimulatory molecules CD80 and
CD86, some express markers such as CD5 and CD45RC
associated with rat pDCs [29], and they have a phenotypic
resemblance to CD11c+ mouse pDCs [32]. Whereas most do
not express the CD45R (B220) isoform of CD45, they do
express the CD45RC isoform, which has also been associ-
ated with pDCs [29]. Further studies are required to probe the
relationship of these cells to pDCs [29], both phenotypically
(expression of CD200) and functionally (production of
interferon-alpha in response to TLR9 ligands). It is noteworthy
that small numbers of pDCs have been described in human
rheumatoid synovium [42].Page 11 of 13
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T cell-induced inflammation in synovium is accompanied by
increases in mDCs, Mϕ, and an incompletely characterised
subset of MHC IIhiCD11b- non-lymphoid cells. Further studies
are required to determine whether these increases are due to
greater precursor recruitment and/or retention and local matu-
ration. The presence of many MHC IIhi monocyte-like cells in
inflamed SRT suggests that differentiation of monocytes is
deviated toward DCs, while the smaller proportion of 'indeter-
minate' cells and the greater numbers of cells that express co-
stimulatory molecules suggest that these cells will be function-
ally different from those in normal SRT. The large numbers of
activated DCs in target tissues of autoimmunity [12,43], there-
fore, may result from the encounter between autoreactive
effector T cells and immature DCs and these cells may exac-
erbate disease by permitting recursive cycles of T-cell
activation.
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